FDA Brief

Warning letters Drugs

FDA warning letter to

Sterling Pharmaceutical Services, LLC

High riskIssued Sep 27, 2022Posted Oct 4, 2022Division of Pharmaceutical Quality Operations III

Sterling Pharmaceutical Services, LLC made sterile ophthalmic drugs with manufacturing violations and marketed unapproved new drugs.

What happened

FDA inspected the Dupo, Illinois facility from February 7 to 18, 2022 and found significant violations of current good manufacturing practice (CGMP) for sterile ophthalmic drugs. The violations included inadequate investigations of persistent microbiological contamination in critical aseptic areas and a sterility failure, inadequate environmental monitoring, and poor aseptic practices. FDA also reviewed labels collected during the inspection and found the products were unapproved new drugs.

What FDA found

  1. The firm did not thoroughly investigate unexplained batch failures or adverse environmental monitoring trends, including a sterility failure in an ophthalmic lot.

    21 CFR 211.192
  2. The firm lacked an adequate environmental monitoring system for aseptic processing areas, including insufficient non-viable particulate and personnel monitoring.

    21 CFR 211.42(c)(10)(iv)
  3. The firm did not establish or follow adequate written procedures to prevent microbiological contamination and validate aseptic and sterilization processes.

    21 CFR 211.113(b)
  4. The firm marketed ophthalmic drug products as new drugs without FDA-approved applications.

    FD&C Act sections 301(d) and 505(a), 21 U.S.C. 331(d), 355(a)

What FDA wants

FDA tells the firm to correct the violations promptly and to provide comprehensive independent risk assessments, remediation plans, corrective action plans, and related data in a written response within 15 working days.

Who should pay attention

  • brands that use this contract manufacturer for sterile ophthalmic drugs
  • distributors and retailers selling homeopathic eye drops or ointments
  • patients and caregivers using ophthalmic drugs, especially for young children

This is a summary. Read the original letter on fda.gov.

Sterling Pharmaceutical Services, LLC's FDA history

Recalls in the last 12 months

Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
TRP The Relief Products* Gentle Eyes Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Sterile Eye Drops, 0.5 FL OZ (15 mL) bottles, Manufactured exclusively for TRP Company, Inc. 1575 Delucci Ln, Reno, NV 89502, …
Lack of Assurance of Sterility
Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops, Sterile, 0.5 FL OZ (15 mL) EACH, 1.0 FL OZ (30 mL) TOTAL, 2 count Twin Pack, Distributed by: AVKARE, Pulaski, TN, 38478, NDC 50268-068-0…
Lack of Assurance of Sterility
Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
AvKare Carboxymethylcellulose Sodium Ophthalmic Solution 0.5%, Lubricant Eye Drops, Sterile, 0.5 FL OZ (15 mL) bottle, Distributed by: AVKARE, Pulaski, TN, 38478, NDC 50268-068-15
Lack of Assurance of Sterility
Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
Lubricant Eye Drops-Cameron Pharmaceuticals, Carboxymethylcellulose Sodium 0.5%, Eye Lubricant, 0.5 FL OZ (15 mL) bottles, Distributed by Cameron Pharmaceuticals, LLC, Louisville, KY, 40245, NDC 42494-448-05
Lack of Assurance of Sterility
Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
Reliable -1 Laboratories, Sodium Chloride Hypertonicity Ophthalmic Solution, 5%, Sterile, 0.5 FL OZ (15 mL) bottles, Distributed by: Reliable-1 Laboratories LLC, Valley Stream, NY, 11580, NDC 69618-077-55.
Lack of Assurance of Sterility
Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
Walgreens Lubricant Eye Drops, 0.5 FL OZ (15 mL) 1.0 FL OZ (30 mL) TOTAL, 2 count Twin Pack, Distributed by Walgreens Co., 200 Wilmot Road, Deerfield, IL 60015, NDC 0363-8833-15.
Lack of Assurance of Sterility
Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
Major LubriFresh P.M. Nighttime Ointment, Net wt. 0.125 oz. (3.5 g) tubes, Distributed by: Major Pharmaceuticals, 17177 N Laurel Park Drive, Suite 233, Livonia, MI 48152, NDC 0904-6488-38
Lack of Assurance of Sterility
Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
Walgreens Lubricant Eye Drops, Carboxymethylcellulose sodium 0.5%, Lubricant Eye Drops, Sterile, 0.5 OZ (15 mL) bottles, Distributed by Walgreen Co., 200 Wilmot Rd., Deerfield, IL 60015, NDC 0363-8833-15.
Lack of Assurance of Sterility
Sep 30 Class II Sterling Pharmaceutical Services LLC
Drug
Reliable-1 Laboratories Lubricating Tears, Sterile, 0.5 FL OZ (15 mL) bottles, Distributed by: Reliable-1 Laboratories LLC, Valley Stream, NY, 11580, www.reliable1labs.com, NDC 69618-076-55.
Lack of Assurance of Sterility

Full company page

Similar letters to other companies

  1. Shenzhen Benliju Biotech Co., Ltd.

    FDA: Shenzhen Benliju Biotech released OTC drugs labeled sterile without sterility testing or process validation.

    High risk
  2. Northland Nuclear Medicine, LLC

    FDA warned Northland Nuclear Medicine in Bismarck, ND, that its PET drugs are adulterated because it failed to investigate microbial contamination and low yields.

    High risk
  3. Rohto Pharmaceutical Co., Ltd.

    FDA cites Rohto Vietnam eye-drop plant for falsified sterility records, poor aseptic practices, and unapproved Cooling Eye Drops.

    High risk
  4. Jiangmen Shuizirun Sanitary Articles Co., Ltd.

    FDA warns Chinese OTC drug maker Jiangmen Shuizirun for labeling products sterile without sterilizing them or testing for sterility.

    High risk